{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:59:37Z","timestamp":1773500377000,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX003451"],"award-info":[{"award-number":["I01 BX003451"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["AA023305"],"award-info":[{"award-number":["AA023305"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s00213-020-05650-5","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T10:04:41Z","timestamp":1598609081000},"page":"3729-3739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Positive allosteric modulation of the cannabinoid type-1 receptor (CB1R) in periaqueductal gray (PAG) antagonizes anti-nociceptive and cellular effects of a mu-opioid receptor agonist in morphine-withdrawn rats"],"prefix":"10.1007","volume":"237","author":[{"given":"Udita","family":"Datta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie K.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason W.","family":"Middleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas W.","family":"Gilpin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"issue":"1","key":"5650_CR1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/03602532.2018.1428341","volume":"50","author":"M Alaverdashvili","year":"2018","unstructured":"Alaverdashvili M, Laprairie RB (2018) The future of type 1 cannabinoid receptor allosteric ligands. Drug Metab Rev 50(1):14\u201325","journal-title":"Drug Metab Rev"},{"issue":"6","key":"5650_CR2","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR (2011) Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115(6):1363\u20131381","journal-title":"Anesthesiology"},{"issue":"3","key":"5650_CR3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","volume":"104","author":"MS Angst","year":"2006","unstructured":"Angst MS, Clark JD (2006) Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104(3):570\u2013587","journal-title":"Anesthesiology"},{"issue":"3","key":"5650_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2004.12.049","volume":"45","author":"EE Bagley","year":"2005","unstructured":"Bagley EE, Gerke MB, Vaughan CW, Hack SP, Christie MJ (2005) GABA transporter currents activated by protein kinase A excite midbrain neurons during opioid withdrawal. Neuron 45(3):433\u2013445","journal-title":"Neuron"},{"key":"5650_CR5","first-page":"6","volume":"6","author":"K Befort","year":"2015","unstructured":"Befort K (2015) Interactions of the opioid and cannabinoid systems in reward: insights from knockout studies. Front Pharmacol 6:6","journal-title":"Front Pharmacol"},{"issue":"22","key":"5650_CR6","doi-asserted-by":"crossref","first-page":"7128","DOI":"10.1523\/JNEUROSCI.16-22-07128.1996","volume":"16","author":"B Chieng","year":"1996","unstructured":"Chieng B, Christie MJ (1996) Local opioid withdrawal in rat single periaqueductal gray neurons<em>In Vitro<\/em>. The Journal of Neuroscience 16(22):7128\u20137136","journal-title":"The Journal of Neuroscience"},{"issue":"7","key":"5650_CR7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1046\/j.1440-1681.2000.03291.x","volume":"27","author":"MJ Christie","year":"2000","unstructured":"Christie MJ, Connor M, Vaughan CW, Ingram SL, Bagley EE (2000) Cellular actions of opioids and other analgesics: implications for synergism in pain relief. Clin Exp Pharmacol Physiol 27(7):520\u2013523","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"11","key":"5650_CR8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","volume":"74","author":"DL Cichewicz","year":"2004","unstructured":"Cichewicz DL (2004) Synergistic interactions between cannabinoid and opioid analgesics. Life Sciences 74(11):1317\u20131324","journal-title":"Life Sciences"},{"issue":"3","key":"5650_CR9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/jpet.102.046870","volume":"305","author":"DL Cichewicz","year":"2003","unstructured":"Cichewicz DL, Welch SP (2003) Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Delta 9-tetrahydrocannabinol. J Pharmacol Exp Ther 305(3):812\u2013817","journal-title":"J Pharmacol Exp Ther"},{"issue":"1-2","key":"5650_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2007.04.010","volume":"567","author":"ML Cox","year":"2007","unstructured":"Cox ML, Haller VL, Welch SP (2007) Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat. Eur J Pharmacol 567(1-2):125\u2013130","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"5650_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-6147(90)90322-Y","volume":"11","author":"SM Crain","year":"1990","unstructured":"Crain SM, Shen KF (1990) Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci 11(2):77\u201381","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"5650_CR12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(92)90417-8","volume":"575","author":"SM Crain","year":"1992","unstructured":"Crain SM, Shen KF (1992) After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res 575(1):13\u201324","journal-title":"Brain Res"},{"issue":"10","key":"5650_CR13","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.biopsych.2018.09.003","volume":"84","author":"JP De Aquino","year":"2018","unstructured":"De Aquino JP, Ross DA (2018) Cannabinoids and pain: weeding out undesired effects with a novel approach to analgesia. Biological Psychiatry 84(10):e67\u2013e69","journal-title":"Biological Psychiatry"},{"issue":"6","key":"5650_CR14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/187152709789824660","volume":"8","author":"J Guindon","year":"2009","unstructured":"Guindon J, Hohmann AG (2009) The endocannabinoid system and pain. CNS Neurol Disord Drug Targets 8(6):403\u2013421","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"15","key":"5650_CR15","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1097\/00001756-199910190-00001","volume":"10","author":"N Hirakawa","year":"1999","unstructured":"Hirakawa N, Tershner SA, Fields HL (1999) Highly delta selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO. Neuroreport 10(15):3125\u20133129","journal-title":"Neuroreport"},{"issue":"13","key":"5650_CR16","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/npp.2015.148","volume":"40","author":"BM Ignatowska-Jankowska","year":"2015","unstructured":"Ignatowska-Jankowska BM, Baillie GL, Kinsey S, Crowe M, Ghosh S, Owens RA, Damaj IM, Poklis J, Wiley JL, Zanda M, Zanato C, Greig IR, Lichtman AH, Ross RA (2015) A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects. Neuropsychopharmacology 40(13):2948\u20132959","journal-title":"Neuropsychopharmacology"},{"issue":"24","key":"5650_CR17","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1523\/JNEUROSCI.18-24-10269.1998","volume":"18","author":"SL Ingram","year":"1998","unstructured":"Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ (1998) Enhanced Opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. The Journal of Neuroscience 18(24):10269\u201310276","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"5650_CR18","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1038\/sj.npp.1301634","volume":"33","author":"SL Ingram","year":"2008","unstructured":"Ingram SL, Macey TA, Fossum EN, Morgan MM (2008) Tolerance to repeated morphine administration is associated with increased potency of opioid agonists. Neuropsychopharmacology 33(10):2494\u20132504","journal-title":"Neuropsychopharmacology"},{"key":"5650_CR19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2017.05.018","volume":"124","author":"L Khurana","year":"2017","unstructured":"Khurana L, Mackie K, Piomelli D, Kendall DA (2017) Modulation of CB1 cannabinoid receptor by allosteric ligands: pharmacology and therapeutic opportunities. Neuropharmacology 124:3\u201312","journal-title":"Neuropharmacology"},{"issue":"1","key":"5650_CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuroscience.2005.06.014","volume":"135","author":"DA Lane","year":"2005","unstructured":"Lane DA, Patel PA, Morgan MM (2005) Evidence for an intrinsic mechanism of antinociceptive tolerance within the ventrolateral periaqueductal gray of rats. Neuroscience 135(1):227\u2013234","journal-title":"Neuroscience"},{"issue":"6","key":"5650_CR21","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1021\/acschemneuro.6b00310","volume":"8","author":"RB Laprairie","year":"2017","unstructured":"Laprairie RB, Kulkarni PM, Deschamps JR, Kelly MEM, Janero DR, Cascio MG, Stevenson LA, Pertwee RG, Kenakin TP, Denovan-Wright EM, Thakur GA (2017) Enantiospecific allosteric modulation of cannabinoid 1 receptor. ACS Chemical Neuroscience 8(6):1188\u20131203","journal-title":"ACS Chemical Neuroscience"},{"issue":"2","key":"5650_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"M Lee","year":"2011","unstructured":"Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L (2011) A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14(2):145\u2013161","journal-title":"Pain Physician"},{"issue":"3","key":"5650_CR23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/jpet.113.204099","volume":"345","author":"DR Maguire","year":"2013","unstructured":"Maguire DR, Yang W, France CP (2013) Interactions between mu-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration. J Pharmacol Exp Ther 345(3):354\u2013362","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"5650_CR24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1096\/fj.06-7132com","volume":"21","author":"L Martini","year":"2007","unstructured":"Martini L, Waldhoer M, Pusch M, Kharazia V, Fong J, Lee JH, Freissmuth C, Whistler JL (2007) Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1. FASEB J 21(3):802\u2013811","journal-title":"FASEB J"},{"issue":"8","key":"5650_CR25","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.neuropharm.2007.03.002","volume":"52","author":"PJ Meyer","year":"2007","unstructured":"Meyer PJ, Fossum EN, Ingram SL, Morgan MM (2007) Analgesic tolerance to microinjection of the micro-opioid agonist DAMGO into the ventrolateral periaqueductal gray. Neuropharmacology 52(8):1580\u20131585","journal-title":"Neuropharmacology"},{"issue":"6","key":"5650_CR26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan MJ (2002) Descending control of pain. Prog Neurobiol 66(6):355\u2013474","journal-title":"Prog Neurobiol"},{"issue":"1","key":"5650_CR27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(86)91367-3","volume":"397","author":"JL Moreau","year":"1986","unstructured":"Moreau JL, Fields HL (1986) Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res 397(1):37\u201346","journal-title":"Brain Res"},{"issue":"1-2","key":"5650_CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pain.2004.09.039","volume":"113","author":"MM Morgan","year":"2005","unstructured":"Morgan MM, Clayton CC, Boyer-Quick JS (2005) Differential susceptibility of the PAG and RVM to tolerance to the antinociceptive effect of morphine in the rat. Pain 113(1-2):91\u201398","journal-title":"Pain"},{"issue":"9","key":"5650_CR29","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/npp.2017.51","volume":"42","author":"S Nielsen","year":"2017","unstructured":"Nielsen S, Sabioni P, Trigo JM, Ware MA, Betz-Stablein BD, Murnion B, Lintzeris N, Khor KE, Farrell M, Smith A, Le Foll B (2017) Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis. Neuropsychopharmacology 42(9):1752\u20131765","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"5650_CR30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","volume":"148","author":"C Rios","year":"2006","unstructured":"Rios C, Gomes I, Devi LA (2006) mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 148(4):387\u2013395","journal-title":"Br J Pharmacol"},{"key":"5650_CR31","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuroscience.2016.06.029","volume":"338","author":"LA Roeckel","year":"2016","unstructured":"Roeckel LA, Le Coz GM, Gaveriaux-Ruff C, Simonin F (2016) Opioid-induced hyperalgesia: cellular and molecular mechanisms. Neuroscience 338:160\u2013182","journal-title":"Neuroscience"},{"issue":"50-51","key":"5650_CR32","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM (2016) Increases in drug and opioid overdose deaths--United States, 2000-2014. MMWR Morb Mortal Wkly Rep 64(50-51):1378\u20131382","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"5650_CR33","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopsych.2017.06.032","volume":"84","author":"RA Slivicki","year":"2018","unstructured":"Slivicki RA, Xu Z, Kulkarni PM, Pertwee RG, Mackie K, Thakur GA, Hohmann AG (2018) Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence. Biol Psychiatry 84(10):722\u2013733","journal-title":"Biol Psychiatry"},{"key":"5650_CR34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnmol.2020.00054","volume":"13","author":"RA Slivicki","year":"2020","unstructured":"Slivicki RA, Iyer V, Mali SS, Garai S, Thakur GA, Crystal JD, Hohmann AG (2020) Positive allosteric modulation of CB1 cannabinoid receptor signaling enhances morphine antinociception and attenuates morphine tolerance without enhancing morphine- induced dependence or reward. Front Mol Neurosci 13:54","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"5650_CR35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjp.0706045","volume":"144","author":"SM Tham","year":"2005","unstructured":"Tham SM, Angus JA, Tudor EM, Wright CE (2005) Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice. Br J Pharmacol 144(6):875\u2013884","journal-title":"Br J Pharmacol"},{"issue":"3","key":"5650_CR36","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.neuron.2007.07.012","volume":"55","author":"I Tracey","year":"2007","unstructured":"Tracey I, Mantyh PW (2007) The cerebral signature for pain perception and its modulation. Neuron 55(3):377\u2013391","journal-title":"Neuron"},{"issue":"41","key":"5650_CR37","doi-asserted-by":"crossref","first-page":"13879","DOI":"10.1523\/JNEUROSCI.2711-15.2015","volume":"35","author":"T Trang","year":"2015","unstructured":"Trang T, Al-Hasani R, Salvemini D, Salter MW, Gutstein H, Cahill CM (2015) Pain and poppies: the good, the bad, and the ugly of opioid analgesics. J Neurosci 35(41):13879\u201313888","journal-title":"J Neurosci"},{"issue":"6660","key":"5650_CR38","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/37610","volume":"390","author":"CW Vaughan","year":"1997","unstructured":"Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390(6660):611\u2013614","journal-title":"Nature"},{"issue":"4","key":"5650_CR39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.j.pain.0000460357.01998.f1","volume":"156","author":"KE Vowles","year":"2015","unstructured":"Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN (2015) Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 156(4):569\u2013576","journal-title":"Pain"},{"issue":"2","key":"5650_CR40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09540260902782794","volume":"21","author":"SP Welch","year":"2009","unstructured":"Welch SP (2009) Interaction of the cannabinoid and opioid systems in the modulation of nociception. International Review of Psychiatry 21(2):143\u2013151","journal-title":"International Review of Psychiatry"},{"issue":"1","key":"5650_CR41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/can.2018.0022","volume":"3","author":"B Wiese","year":"2018","unstructured":"Wiese B, Wilson-Poe AR (2018) Emerging evidence for cannabis\u2019 role in opioid use disorder. Cannabis and Cannabinoid Research 3(1):179\u2013189","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"1","key":"5650_CR42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","volume":"65","author":"JT Williams","year":"2013","unstructured":"Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, Christie MJ (2013) Regulation of mu-opioid receptors: desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65(1):223\u2013254","journal-title":"Pharmacol Rev"},{"issue":"6828","key":"5650_CR43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","volume":"410","author":"RI Wilson","year":"2001","unstructured":"Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410(6828):588\u2013592","journal-title":"Nature"},{"issue":"7","key":"5650_CR44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.neuropharm.2008.07.038","volume":"55","author":"AR Wilson","year":"2008","unstructured":"Wilson AR, Maher L, Morgan MM (2008) Repeated cannabinoid injections into the rat periaqueductal gray enhance subsequent morphine antinociception. Neuropharmacology 55(7):1219\u20131225","journal-title":"Neuropharmacology"},{"key":"5650_CR45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroscience.2012.03.038","volume":"213","author":"AR Wilson-Poe","year":"2012","unstructured":"Wilson-Poe AR, Morgan MM, Aicher SA, Hegarty DM (2012) Distribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal gray. Neuroscience 213:191\u2013200","journal-title":"Neuroscience"},{"issue":"2","key":"5650_CR46","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bph.12809","volume":"172","author":"AR Wilson-Poe","year":"2015","unstructured":"Wilson-Poe AR, Lau BK, Vaughan CW (2015) Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey. Br J Pharmacol 172(2):681\u2013690","journal-title":"Br J Pharmacol"},{"issue":"20","key":"5650_CR47","doi-asserted-by":"crossref","first-page":"6541","DOI":"10.1113\/JP274157","volume":"595","author":"AR Wilson-Poe","year":"2017","unstructured":"Wilson-Poe AR, Jeong HJ, Vaughan CW (2017) Chronic morphine reduces the readily releasable pool of GABA, a presynaptic mechanism of opioid tolerance. J Physiol 595(20):6541\u20136555","journal-title":"J Physiol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-020-05650-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-020-05650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T23:21:35Z","timestamp":1630106495000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-020-05650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5650"],"URL":"https:\/\/doi.org\/10.1007\/s00213-020-05650-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"13 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of the Louisiana State University Health Sciences Center and were in accordance with the National Institute of Health guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NWG is a consultant for Glauser Life Sciences, Inc. All other authors report no biomedical financial interests or potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}